Entera Bio (ENTX) Gross Profit (2021 - 2024)

Entera Bio has disclosed Gross Profit across 3 years of filings, most recently posting $9000.0 for Q2 2024.

• Quarterly Gross Profit changed N/A year-over-year to $9000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $9000.0 (changed N/A YoY) and the FY2024 annual result came in at $9000.0, changed N/A from the prior year.
• Gross Profit climbed to $9000.0 in Q2 2024, from $6000.0 in the prior quarter.
• Over five years, Gross Profit peaked at $84000.0 in Q1 2021 and troughed at $2000.0 in Q3 2022.
• A 3-year average of $26666.7 and a median of $11000.0 in 2022 frame the typical range for Gross Profit.
• Biggest YoY gain for Gross Profit was 10.0% in 2022; the steepest drop was 97.33% in 2022.
• Tracing ENTX's Gross Profit over 3 years: stood at $29000.0 in 2021, then tumbled by 79.31% to $6000.0 in 2022, then soared by 50.0% to $9000.0 in 2024.
• Business Quant data shows ENTX's Gross Profit at $9000.0 in Q2 2024, $6000.0 in Q4 2022, and $2000.0 in Q3 2022.